Biomedical Engineering Research Services

Biomedical engineering applies engineering to biology and medicine: biomechanics, medical devices, imaging, biosignal processing, tissue engineering, rehabilitation and health informatics. Work in this area often involves human or animal data, ethical oversight and regulation, which shape what can be done and what can be claimed. We provide support for modelling, simulation, signal and image analysis, statistical design and manuscript preparation. We do not provide clinical advice, diagnosis, device certification or regulatory submissions, and we never present research outputs as medical recommendations.

Finite element models of bones, joints, soft tissues and implants help study stress distribution, wear and healing. Geometry from imaging, material properties from the literature or experiments, and boundary conditions from motion analysis all carry uncertainty. Patient-specific models are especially sensitive to segmentation and material assumptions. Verification through mesh convergence and validation against experimental strain or displacement measurements are essential before conclusions are drawn.

We support model construction, sensitivity analysis on uncertain parameters, validation planning and clear reporting of limitations. Results are framed as research findings, not clinical predictions.

Biosignals are noisy, non-stationary and subject-dependent. Preprocessing choices, such as filtering, artefact removal and segmentation, affect downstream results, and features that work in one cohort may not generalise. Evaluation must separate subjects between training and testing, otherwise performance is inflated by subject-specific patterns. Reporting should include sensitivity, specificity, confidence intervals and the class balance of the dataset.

We help design signal-processing pipelines, perform subject-wise cross-validation, analyse errors and prepare figures. We encourage use of public benchmark datasets alongside new data to enable comparison.

Segmentation, registration and classification of medical images are increasingly done with deep learning. Credible studies describe the scanner and protocol, annotation process and inter-observer variability, and evaluate on data from sites not used in training. Metrics such as Dice coefficient, Hausdorff distance or area under the curve should be accompanied by confidence intervals and examples of failures.

We support experiment design, evaluation, statistical comparison against baselines and honest discussion of limitations, including dataset bias and lack of external validation.

Research on wearable and implantable sensors addresses accuracy, power consumption, biocompatibility and user comfort. Bench tests against reference instruments, with Bland-Altman analysis and error metrics across conditions, are standard in validation of measurement devices. Human studies need ethics approval and defined protocols.

We help plan validation experiments, analyse agreement statistics and write results in a way that distinguishes proof of concept from clinical validation.

Studies on people require ethics approval, informed consent, privacy protection and appropriate sample-sise justification. Retrospective datasets carry selection bias and missing data. Pre-specified analysis plans reduce the risk of selective reporting, and reporting guidelines such as those for diagnostic accuracy or prediction models improve transparency.

We help with statistical planning, analysis and compliance with reporting checklists, but responsibility for ethical approval and data protection rests with the investigators and their institutions.

Exoskeletons, prosthetics and assistive devices are evaluated with gait analysis, electromyography, user-experience surveys and usability testing. Small participant numbers are common, so within-subject designs, effect sizes and cautious conclusions are appropriate. Heterogeneity among users must be discussed rather than averaged away.

We support experimental design, analysis of kinematic and kinetic data and writing of user-centred evaluations.

Reviewers expect clear description of participants or specimens, ethics statements, validation against accepted references and discussion of clinical relevance without overstatement. Limitations such as small sample size, single-centre data or lack of long-term follow-up must be explicit.

Our manuscript services help structure papers, prepare figures and tables, and align reporting with relevant guidelines, using only the authors' data. Publication outcomes cannot be guaranteed.

Share the research question, the data or models available, and the target venue. We will indicate what analysis and writing support is feasible and where clinical, regulatory or laboratory expertise must come from your own team.

Scaffolds, hydrogels, coatings and delivery systems are assessed for mechanical properties, degradation, release kinetics and biological response. Release profiles are fitted with models such as first-order, Higuchi or Korsmeyer-Peppas, but a good fit does not by itself prove a mechanism. Mechanical tests should be done in hydrated conditions at relevant temperatures, with enough specimens to show variability.

Biological evaluation, including cell culture, animal work and biocompatibility testing, requires specialised laboratories and ethics approval. We do not conduct or certify such work; we support experimental planning, statistical analysis of the results the authors obtain and manuscript preparation.

We encourage explicit statements of the number of independent experiments, the replicate structure and the statistical tests used, since in-vitro work often confuses technical replicates with independent biological replicates.

Computational fluid dynamics of blood flow and airflow supports research on stenosis, aneurysms, valves, stents and ventilation. Results depend on geometry reconstruction, boundary conditions, vessel wall compliance and blood rheology. Patient-specific boundary conditions are rarely measured completely, so assumptions must be stated and their influence tested.

Validation uses phantoms, particle image velocimetry or clinical imaging where available. Haemodynamic indices such as wall shear stress are sensitive to mesh resolution and should be reported with convergence evidence.

We support model set-up review, sensitivity studies and presentation, framing outputs as research results and not as clinical decision tools.

Prediction models using clinical, imaging or sensor data suffer from dataset shift, label noise and confounding by site or device. A model reporting high accuracy on a random split may fail on a new hospital. External validation, calibration assessment and decision-curve thinking are more informative than accuracy alone.

Explainability tools provide hypotheses, not proof of causal mechanism, and should be presented accordingly. Privacy-preserving practices and consent for secondary use of data are the responsibility of the data controller.

We help with study design, validation strategy, metric selection and writing in line with reporting guidance for prediction-model studies.

A device prototype that works in the laboratory is far from an approved medical device. Risk management, quality systems, clinical evaluation and post-market surveillance form a large part of real-world development. Manuscripts should avoid language suggesting readiness for clinical use unless supported by proper evidence and regulatory pathways.

We can help authors discuss translational pathways in general terms and cite relevant standards, but we do not provide regulatory strategy or submissions.

Health data are sensitive, and secondary use requires a legal basis, de-identification and governance. Re-identification risk is higher than it seems when images, dates or rare conditions are included. Authors should describe consent, approvals and data access arrangements, and avoid sharing raw patient data without permission.

We can help structure data management plans and ethics statements for research, but legal compliance depends on local regulation and institutional policy, which investigators must confirm with their data protection officers.

Reproducibility in biomedical computation requires fixed software versions, random seeds, documented preprocessing and a record of the data splits. Sharing code and, where permitted, derived or synthetic data lets readers verify analysis. Containerised environments reduce setup problems for others.

We help organise analysis scripts, document parameters and prepare availability statements that match journal policy.

Engineering studies often motivate work with clinical need, but claims of clinical benefit require clinical evidence. Phrases such as may assist clinicians or could support future evaluation are more accurate than suggestions of diagnostic capability. The limitations section should name the missing steps, such as prospective validation, usability testing and regulatory review.

Our writing support helps keep the discussion accurate and measured while still conveying the potential of the work.

Biomedical projects need engineers, clinicians, biologists and statisticians to agree on definitions and endpoints early. A shared glossary and a clear definition of the clinical reference standard prevent mismatches between technical performance and clinical meaning.

We help prepare clear, accessible descriptions that serve both engineering and clinical readers.